Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002)
about
Identification and characterization of cancer stem cells in canine mammary tumorsSurvey radiography and computerized tomography imaging of the thorax in female dogs with mammary tumorsProperties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.Mouse mammary tumor virus-like nucleotide sequences in canine and feline mammary tumors.Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.Tumor slices as a model to evaluate doxorubicin in vitro treatment and expression of trios of genes PRSS11, MTSS1, CLPTM1 and PRSS11, MTSS1, SMYD2 in canine mammary gland cancer.Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.Effect of Ovariohysterectomy at the Time of Tumor Removal in Dogs with Mammary Carcinomas: A Randomized Controlled TrialInflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment.A review of sentinel lymph node evaluation and the need for its incorporation into veterinary oncology.Relationship between major histocompatibility complex class I expression and prognosis in canine mammary gland tumorsCanine mammary tumours, an overview.Canine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time.Prognostic impact of neoadjuvant aglepristone treatment in clinicopathological parameters of progesterone receptor-positive canine mammary carcinomas.Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis.Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.Effect of ovariohysterectomy at the time of tumor removal in dogs with benign mammary tumors and hyperplastic lesions: a randomized controlled clinical trial.Fine-needle aspiration biopsy of canine mammary gland tumours: a comparison between cytology and histopathology.Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms.Clinicopathological Diversity of Canine Mammary Gland Tumors in Sri Lanka: A One-Year Survey on Cases Presented to Two Veterinary Practices.Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.Major medical causes by breed and life stage for dogs presented at veterinary clinics in the Republic of Korea: a survey of electronic medical records.Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks
P2860
Q28067454-009521F6-FD3E-4B78-93C2-DE4AF577E754Q33746049-EAA5EFF8-97E3-4B48-9047-CAF65AF55A5BQ34333126-C959A178-E8A1-4D7D-A398-FB037B275FE1Q34433114-C4EBB27C-6A99-4A90-AC5A-D185995CE741Q35775363-37514190-E2D5-43FD-8151-CD4705D4DC22Q36775658-63330FA3-D4B2-4F23-84FE-AF43AB1FA2EBQ36873505-28FD7241-0C52-4188-A0D4-6D7F7D86EE85Q37020475-AAB43C80-532B-4767-8D75-0A5B71C11BC7Q37165892-095BAE79-60A9-4991-A8C0-F1C866A0E4B8Q37488370-EBB5B454-8234-4D7D-9CEB-FD9152C9AD42Q37618172-1E85F5D9-84A8-4BF9-B3EE-40AEF8B6E7CBQ37885436-4A730531-FADB-4725-83BC-A4BB998599B3Q40034698-1B079A5A-0792-4AED-9987-4333B2A3FCF6Q40093120-A36FE020-2C7B-48AC-97D7-472DF4F4FE49Q43989152-158554E9-123E-4604-A6BD-E94E55D8530AQ44477076-7EF4A381-82C1-4026-9E03-AE5B01BC0AE1Q46271916-56CC97D1-5C12-4E0D-B045-B890679C2663Q46278669-2A248001-7178-495D-ADA0-13A6562A9DE4Q51458614-D62E8762-6660-4802-A85F-AF709BFADF44Q51528964-06738515-DE79-4493-A67B-76907E625302Q52558390-0EA259E5-DCBE-40BE-B615-83CC4FD1A9CDQ53104819-6CEE4A74-8068-4F03-96CF-98B1D8AA103BQ55662561-6817F7F3-7914-4B4A-8E35-C4E943971066Q57168404-F07BF364-E59A-40DD-8E5C-B11C804C0394
P2860
Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002)
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Prognostic factors associated ...... y tumors: 79 cases (1998-2002)
@ast
Prognostic factors associated ...... y tumors: 79 cases (1998-2002)
@en
Prognostic factors associated ...... y tumors: 79 cases (1998-2002)
@nl
type
label
Prognostic factors associated ...... y tumors: 79 cases (1998-2002)
@ast
Prognostic factors associated ...... y tumors: 79 cases (1998-2002)
@en
Prognostic factors associated ...... y tumors: 79 cases (1998-2002)
@nl
prefLabel
Prognostic factors associated ...... y tumors: 79 cases (1998-2002)
@ast
Prognostic factors associated ...... y tumors: 79 cases (1998-2002)
@en
Prognostic factors associated ...... y tumors: 79 cases (1998-2002)
@nl
P2093
P1476
Prognostic factors associated ...... y tumors: 79 cases (1998-2002)
@en
P2093
Chao-Chin Chang
Min-Liang Wong
Shih-Chieh Chang
Tien-Jye Chang
P304
P356
10.2460/JAVMA.2005.227.1625
P407
P577
2005-11-15T00:00:00Z